For many women, reproductive health can feel like a collection of unanswered questions. Is this pain normal? Is my cycle irregular enough to mention? Should I ask for testing now, or wait until I want to become pregnant? What happens when a doctor says everything looks fine, yet something still feels wrong?

Those questions sit at the center of Mira’s “A Woman’s Maze” campaign , announced alongside actress and advocate Rumer Willis, who becomes the company’s first Global Brand Ambassador. The initiative seeks to address the confusion, dismissed symptoms and gaps in education that often shape women’s experiences with hormonal and reproductive care .

A May 2026 company survey of 1,200 women found that 97% wanted to know more about their bodies rather than simply treat symptoms. Yet 95% said they felt left to figure out their own health. Nearly three-quarters had searched Google or ChatGPT for answers they felt they could not get from a doctor. At the same time, the same percentage had delayed professional care after convincing themselves that their symptoms were normal or that they should tolerate them.

The findings are company-sponsored and should be viewed in that context. Still, the experiences behind the figures will feel familiar to many women who have spent years questioning whether their pain, bleeding, fatigue, mood changes, or cycle shifts warranted medical attention.

Women Are Often Taught To Doubt Their Own Bodies

Willis has spent four years tracking her hormones through irregular cycles, conception, and postpartum changes. That process, she said, challenged a pattern many women learn early: trusting an outside opinion before trusting their own experience.

“Our default is to outsource our bodies,” Willis said. “We’re not taught to cultivate trust in ourselves.”

She described how someone trying to conceive may repeatedly miss ovulation while an app predicts a fertile window based on averages. A doctor may say the person is healthy, yet pregnancy does not occur, leaving them with little clarity about what might be happening.

“Those pieces can leave you feeling hopeless because you don’t know what is going on,” Willis said. “Most apps work off your average, but when I started using Mira, I realized my cycle was totally different. If I had relied on that average, I would have been missing my window.”

The Mira hormone monitoring system measures numerical concentrations of reproductive hormones through urine test wands, a handheld analyzer, and a mobile app. Rather than producing a simple positive or negative ovulation result, it records hormone shifts across the cycle and presents them in visual reports. The system uses fluorescent detection, a light-based method that reads hormone signals within the analyzer rather than requiring users to interpret the color of a test line.

Mira states that its products are intended for hormone monitoring and cycle tracking, rather than diagnosing conditions such as polycystic ovary syndrome. That distinction matters. Home data may reveal a pattern worth discussing, but it cannot replace a clinician’s evaluation, medical testing or diagnosis.

For Willis, seeing her personal patterns changed the way she viewed her reproductive health.

“I learned that my progesterone was very low,” she said. “There is so much information that can be gained from having that insight, whether someone is thinking about fertility, perimenopause, PCOS or endometriosis.”

Women Still Struggle To Have Their Symptoms Taken Seriously

The need for better information exists within a much larger problem. UN Women has documented persistent gaps in women’s healthcare , including limited research, unequal access to services and health systems that do not consistently address women’s needs. Medical dismissal can also affect whether patients seek care again. Harvard Health has examined the dangerous dismissal of women’s pain , particularly when symptoms are minimized, attributed to emotion, or treated as less credible.

Willis recalled a recent gynecology appointment that lasted less than four minutes.

“It was staggering, and I was horrified,” she said. “I found it fascinating because that is considered a standard of care. How can you feel safe sharing that you are having pain during sex, breast pain or another concern when there is no support or time?”

That experience helps explain why women may turn to search engines, social platforms, and artificial intelligence. They may be seeking medical information, but Willis believes many are also seeking confirmation that their fears deserve attention.

“We’re outsourcing our fear to someone who can validate it,” she said. “Sometimes we’re hoping to find out that nothing is wrong, and sometimes we know something is going on. Think about how many women with endometriosis or PCOS are desperate for someone to say, ‘Yes, something is wrong.’ Instead, they are told there is nothing wrong with them.”

Research has found that gender bias can influence the recognition and treatment of pain, including how symptoms are assessed and how quickly patients receive care. Published medical literature has also examined gender-based disparities in pain assessment and treatment , adding clinical context to experiences women have described for years.

Women Can Use Data To Ask More Specific Questions

Since tracking her hormones, Willis said she has become more proactive during medical appointments. She now requests regular bloodwork to establish personal baselines and notice meaningful changes.

“I want to be proactive and be the healthiest I can be,” she said. “My advice is to start learning what your body does before there is a problem. Track your cycle. Learn your baseline symptoms. If you don’t know what your baseline is, it is much harder to recognize when something changes.”

She compared that self-trust to the instinct many parents develop with their children.

“I know my daughter better than anyone else,” Willis said. “Learning to trust myself with my own body has helped me speak up for myself and advocate for friends.”

That became especially clear when she served as a doula for a friend. Supporting someone else through childbirth forced her to question the hesitation women can feel when challenging a medical professional or asking for more information.

“I kept thinking, ‘Am I allowed to do this?’” she recalled. “Then I realized I’m her advocate right now.”

Health data can help people arrive at appointments with more precise observations. A cycle chart may show when ovulation appears to occur, whether a hormone rise recurs each month, and whether symptoms correspond to a specific phase. Such records do not provide a diagnosis, but they may help focus the conversation.

Women Want Fertility Information Before A Crisis

Willis would also like fertility education and testing to begin earlier, rather than after months of unsuccessful attempts to conceive.

“I don’t care if you want to have children at 45. You should be testing in your twenties, and it should be part of your annual exam,” she said. “I’ve made a lot of effort to support my body and the family I’m trying to create.”

She specifically raised anti-Müllerian hormone, commonly called AMH, which can offer information about ovarian reserve. AMH is only one part of a fertility assessment and cannot predict whether someone will become pregnant naturally. Still, Willis believes women should be able to request a broader conversation about their reproductive health without facing resistance.

“If a doctor is telling you no, ask again,” she said. “It should be treated like any other test you request as part of caring for your health. It’s concerning that women can face pushback.”

Early information may influence choices about family timing, fertility preservation or whether to seek a specialist’s opinion. It may also create anxiety or be misinterpreted without proper counseling, which is why results should be discussed with a qualified clinician.

Willis believes women deserve the chance to make those decisions with more information.

“What if you’re 22 and you find out your AMH is low?” she said. “You can look at your options. I don’t see harm in giving women the ability to make that choice.”

Women Need Better Education And More Honest Conversations

As part of “A Woman’s Maze,” Mira is asking individuals, advocates and healthcare professionals to support a petition calling for medically accurate sex hormone education in K-12 schools . The effort reflects Willis’s concern that traditional sex education often focuses on pregnancy and sexually transmitted infections without teaching students how menstrual cycles, ovulation, cervical mucus or reproductive hormones function.

“We go through sex education hearing that if you come near sperm, you’ll get pregnant, or that you’ll get an STI,” she said. “We aren’t given the information that helps us make informed choices about what we want.”

Her hopes for the partnership extend beyond product awareness. Willis wants women to feel safer discussing infertility, miscarriage, postpartum health, endometriosis, PCOS and perimenopause. Silence can make each experience feel private and isolating, even when millions of people share it.

“My biggest hope in joining Mira is to shine a light on this conversation and inspire women to ask questions, speak up for themselves and create a community,” she said. “We are all trying to learn about ourselves, and there are tools that can help.”

She also believes men should know more about reproductive hormones, fertility, and the physical changes their partners may experience.

“We used to raise children together and pass information through generations of women,” Willis said. “That has disappeared, and we need to bring it back. Men should have responsibility for learning about their partner’s cycle and their own fertility too.”

For women who have spent years wondering whether their symptoms matter, the first step may be surprisingly simple: write them down, look for patterns, and keep asking for care until someone listens.